UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S. aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model: Exploring the “Seesaw Effect”

Antimicrobial Agents and Chemotherapy, 2013-06, Vol.57 (6), p.2664-2668

2013

Volltextzugriff (PDF)

Community- and health care-associated methicillin-resistant Staphylococcus aureus : a comparison of molecular epidemiology and antimicrobial activities of various agents

Diagnostic microbiology and infectious disease, 2007-05, Vol.58 (1), p.41-47

2007

Volltextzugriff (PDF)

Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus

Infection control and hospital epidemiology, 2006-10, Vol.27 (10), p.1025

2006

Volltextzugriff (PDF)

Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

Antimicrobial Agents and Chemotherapy, 2008-03, Vol.52 (3), p.831-836

2008

Volltextzugriff (PDF)

Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus, Coagulase-Negative Staphylococci, Enterococcus faecalis, and Enterococcus faecium

Antimicrobial Agents and Chemotherapy, 1998-03, Vol.42 (3), p.721-724

1998

Volltextzugriff (PDF)

Characterizing Vancomycin-Resistant Enterococcus Strains with Various Mechanisms of Daptomycin Resistance Developed in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2011-10, Vol.55 (10), p.4748-4754

2011

Volltextzugriff (PDF)

Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus

International journal of antimicrobial agents, 2011-11, Vol.38 (5), p.442-446

2011

Volltextzugriff (PDF)

Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.805-807

2009

Volltextzugriff (PDF)

N-Caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors

Bioorganic & medicinal chemistry letters, 2007-03, Vol.17 (6), p.1755-1758

2007

Volltextzugriff (PDF)

Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus

Bioorganic & medicinal chemistry letters, 2003-07, Vol.13 (13), p.2109-2112

2003

Volltextzugriff (PDF)

In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model

International journal of antimicrobial agents, 2004-08, Vol.24 (2), p.150-160

2004

Volltextzugriff (PDF)

Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus

Antimicrobial agents and chemotherapy, 1999-02, Vol.43 (2), p.335-340

1999

Volltextzugriff (PDF)

Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function

Journal of antimicrobial chemotherapy, 2007-06, Vol.59 (6), p.1190-1193

2007

Volltextzugriff (PDF)

Comparison of a Rabbit Model of Bacterial Endocarditis and an In Vitro Infection Model with Simulated Endocardial Vegetations

Antimicrobial Agents and Chemotherapy, 2000-07, Vol.44 (7), p.1921-1924

2000

Volltextzugriff (PDF)

Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model

Journal of antimicrobial chemotherapy, 2008-05, Vol.61 (5), p.1099-1102

2008

Volltextzugriff (PDF)

Antimicrobial Susceptibility and Staphylococcal Chromosomal Cassette mec Type in Community- and Hospital-Associated Methicillin-Resistant Staphylococcus aureus

Pharmacotherapy, 2007-01, Vol.27 (1), p.3-10

2007

Volltextzugriff (PDF)

Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus

Bioorganic & medicinal chemistry letters, 2003-05, Vol.13 (10), p.1745-1749

2003

Volltextzugriff (PDF)

Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin

Diagnostic microbiology and infectious disease, 2005-02, Vol.51 (2), p.119-125

2005

Volltextzugriff (PDF)

The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model

Journal of antimicrobial chemotherapy, 1999-09, Vol.44 (3), p.343-349

1999

Volltextzugriff (PDF)

Efficacy of Trovafloxacin against Experimental Staphylococcus aureus Endocarditis

Antimicrobial Agents and Chemotherapy, 1998-02, Vol.42 (2), p.254-256

1998

Volltextzugriff (PDF)

Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model

Antimicrobial Agents and Chemotherapy, 1997-06, Vol.41 (6), p.1359-1363

1997

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

ThemaStaphylococcus Aureus - Drug Effects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

3 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Evaluation of Ceftaroline Activity against Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate Methicillin-Resistant S. aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic Model: Exploring the “Seesaw Effect”

Community- and health care-associated methicillin-resistant Staphylococcus aureus : a comparison of molecular epidemiology and antimicrobial activities of various agents

Characteristics of patients with healthcare-associated infection due to SCCmec type IV methicillin-resistant Staphylococcus aureus

Daptomycin Activity against Staphylococcus aureus following Vancomycin Exposure in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations

Comparative In Vitro Activities and Postantibiotic Effects of the Oxazolidinone Compounds Eperezolid (PNU-100592) and Linezolid (PNU-100766) versus Vancomycin against Staphylococcus aureus, Coagulase-Negative Staphylococci, Enterococcus faecalis, and Enterococcus faecium

Characterizing Vancomycin-Resistant Enterococcus Strains with Various Mechanisms of Daptomycin Resistance Developed in an In Vitro Pharmacokinetic/Pharmacodynamic Model

Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus

Impact of Inoculum Size and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA) on Vancomycin Activity and Emergence of VISA in an In Vitro Pharmacodynamic Model

N-Caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors

Structural features of piperazinyl-linked ciprofloxacin dimers required for activity against drug-resistant strains of Staphylococcus aureus

In vitro activities of mutant prevention concentration-targeted concentrations of fluoroquinolones against Staphylococcus aureus in a pharmacodynamic model

Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus

Correlation of vancomycin and daptomycin susceptibility in Staphylococcus aureus in reference to accessory gene regulator (agr) polymorphism and function

Comparison of a Rabbit Model of Bacterial Endocarditis and an In Vitro Infection Model with Simulated Endocardial Vegetations

Teicoplanin pharmacodynamics in reference to the accessory gene regulator (agr) in Staphylococcus aureus using an in vitro pharmacodynamic model

Antimicrobial Susceptibility and Staphylococcal Chromosomal Cassette mec Type in Community- and Hospital-Associated Methicillin-Resistant Staphylococcus aureus

Piperazinyl-linked fluoroquinolone dimers possessing potent antibacterial activity against drug-resistant strains of Staphylococcus aureus

Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin

The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model

Efficacy of Trovafloxacin against Experimental Staphylococcus aureus Endocarditis

Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model

Aktive Filter

Suchergebnisse filtern